文档下载 文档下载导航
设为首页 | 加入收藏
搜索 请输入内容:  
 导航当前位置: 文档下载 > 所有分类 > 自然科学 > 生物学 > Organoid Cultures Derived from Patients with Advanced Prostate Cancer
侵权投诉

Organoid Cultures Derived from Patients with Advanced Prostate Cancer

Organoid Cultures Derived from Patients with Advanced Prostate Cancer

Exomesequencingidenti esrecurrentSPOP,FOXA1andMED12mutationsinprostatecancer.Nat.Genet.44,685–689.

Barker,N.,Huch,M.,Kujala,P.,vandeWetering,M.,Snippert,H.J.,vanEs,J.H.,Sato,T.,Stange,D.E.,Begthel,H.,vandenBorn,M.,etal.(2010).Lgr5(+ve)stemcellsdriveself-renewalinthestomachandbuildlong-livedgastricunitsinvitro.CellStemCell6,25–36.

Barretina,J.,Caponigro,G.,Stransky,N.,Venkatesan,K.,Margolin,A.A.,Kim,

S.,Wilson,C.J.,Leha

´r,J.,Kryukov,G.V.,Sonkin,D.,etal.(2012).TheCancerCellLineEncyclopediaenablespredictivemodellingofanticancerdrugsensi-tivity.Nature483,603–607.

Beltran,H.,Rickman,D.S.,Park,K.,Chae,S.S.,Sboner,A.,MacDonald,T.Y.,Wang,Y.,Sheikh,K.L.,Terry,S.,Tagawa,S.T.,etal.(2011).Molecularcharac-terizationofneuroendocrineprostatecancerandidenti cationofnewdrugtargets.CancerDiscov1,487–495.

Burkhardt,L.,Fuchs,S.,Krohn,A.,Masser,S.,Mader,M.,Kluth,M.,Bach-mann,F.,Huland,H.,Steuber,T.,Graefen,M.,etal.(2013).CHD1isa5q21tumorsuppressorrequiredforERGrearrangementinprostatecancer.CancerRes.73,2795–2805.

CancerGenomeAtlasResearchNetwork(2011).Integratedgenomicanalysesofovariancarcinoma.Nature474,609–615.

Carver,B.S.,Chapinski,C.,Wongvipat,J.,Hieronymus,H.,Chen,Y.,Chandarlapaty,S.,Arora,V.K.,Le,C.,Koutcher,J.,Scher,H.,etal.(2011).ReciprocalfeedbackregulationofPI3KandandrogenreceptorsignalinginPTEN-de cientprostatecancer.CancerCell19,575–586.

Cerami,E.,Gao,J.,Dogrusoz,U.,Gross,B.E.,Sumer,S.O.,Aksoy,B.A.,Jacobsen,A.,Byrne,C.J.,Heuer,M.L.,Larsson,E.,etal.(2012).ThecBiol.cancergenomicsportal:anopenplatformforexploringmultidimensionalcan-cergenomicsdata.CancerDiscov.2,401–404.

Chen,Y.,Chi,P.,Rockowitz,S.,Iaquinta,P.J.,Shamu,T.,Shukla,S.,Gao,D.,Sirota,I.,Carver,B.S.,Wongvipat,J.,etal.(2013).ETSfactorsreprogramtheandrogenreceptorcistromeandprimeprostatetumorigenesisinresponsetoPTENloss.Nat.Med.19,1023–1029.

deBono,J.S.,Logothetis,C.J.,Molina,A.,Fizazi,K.,North,S.,Chu,L.,Chi,K.N.,Jones,R.J.,Goodman,O.B.,Jr.,Saad,F.,etal.;COU-AA-301Investiga-tors(2011).Abirateroneandincreasedsurvivalinmetastaticprostatecancer.N.Engl.J.Med.364,1995–2005.

Demichelis,F.,Setlur,S.R.,Beroukhim,R.,Perner,S.,Korbel,J.O.,Lafargue,C.J.,P ueger,D.,Pina,C.,Hofer,M.D.,Sboner,A.,etal.(2009).DistinctgenomicaberrationsassociatedwithERGrearrangedprostatecancer.GenesChromosomesCancer48,366–380.

Dobin,A.,Davis,C.A.,Schlesinger,F.,Drenkow,J.,Zaleski,C.,Jha,S.,Batut,P.,Chaisson,M.,andGingeras,T.R.(2013).STAR:ultrafastuniversalRNA-seqaligner.Bioinformatics29,15–21.

Druker,B.J.,Tamura,S.,Buchdunger,E.,Ohno,S.,Segal,G.M.,Fanning,S.,Zimmermann,J.,andLydon,N.B.(1996).EffectsofaselectiveinhibitoroftheAbltyrosinekinaseonthegrowthofBcr-Ablpositivecells.Nat.Med.2,561–566.Garnett,M.J.,Edelman,E.J.,Heidorn,S.J.,Greenman,C.D.,Dastur,A.,Lau,K.W.,Greninger,P.,Thompson,I.R.,Luo,X.,Soares,J.,etal.(2012).System-aticidenti cationofgenomicmarkersofdrugsensitivityincancercells.Nature483,570–575.

Grasso,C.S.,Wu,Y.M.,Robinson,D.R.,Cao,X.,Dhanasekaran,S.M.,Khan,A.P.,Quist,M.J.,Jing,X.,Lonigro,R.J.,Brenner,J.C.,etal.(2012).Themuta-tionallandscapeoflethalcastration-resistantprostatecancer.Nature487,239–243.

Horoszewicz,J.S.,Leong,S.S.,Kawinski,E.,Karr,J.P.,Rosenthal,H.,Chu,T.M.,Mirand,E.A.,andMurphy,G.P.(1983).LNCaPmodelofhumanprostaticcarcinoma.CancerRes.43,1809–1818.

Huch,M.,Bonfanti,P.,Boj,S.F.,Sato,T.,Loomans,C.J.,vandeWetering,M.,Sojoodi,M.,Li,V.S.,Schuijers,J.,Gracanin,A.,etal.(2013a).Unlimitedinvitroexpansionofadultbi-potentpancreasprogenitorsthroughtheLgr5/R-spon-dinaxis.EMBOJ.32,2708–2721.

Huch,M.,Dorrell,C.,Boj,S.F.,vanEs,J.H.,Li,V.S.,vandeWetering,M.,Sato,T.,Hamer,K.,Sasaki,N.,Finegold,M.J.,etal.(2013b).Invitroexpansionof

singleLgr5+liverstemcellsinducedbyWnt-drivenregeneration.Nature494,247–250.

Johnson,H.,Zhou,M.,andOsunkoya,A.O.(2013).ERGexpressioninmucinousprostaticadenocarcinomaandprostaticadenocarcinomawithmucinousfeatures:comparisonwithconventionalprostaticadenocarcinoma.Hum.Pathol.44,2241–2246.

Kaighn,M.E.,Lechner,J.F.,Narayan,K.S.,andJones,L.W.(1978).Prostatecarcinoma:tissueculturecelllines.Natl.CancerInst.Monogr.49,17–21.Karthaus,W.R.,Iaquinta,P.J.,Drost,J.,Gracanin,A.,vanBoxtel,R.,Wongvi-pat,J.,Dowling,C.M.,Gao,D.,Begthel,H.,Sachs,N.,etal.(2014).Identi ca-tionofMultipotentLuminalProgenitorCellsinHumanProstateOrganoidCultures.Cell158.PublishedonlineSeptember4,2014.doc.guandang.net.

Korenchuk,S.,Lehr,J.E.,MClean,L.,Lee,Y.G.,Whitney,S.,Vessella,R.,Lin,D.L.,andPienta,K.J.(2001).VCaP,acell-basedmodelsystemofhumanpros-tatecancer.InVivo15,163–168.

Krohn,A.,Seidel,A.,Burkhardt,L.,Bachmann,F.,Mader,M.,Grupp,K.,Eichenauer,T.,Becker,A.,Adam,M.,Graefen,M.,etal.(2013).Recurrentdeletionof3p13targetsmultipletumoursuppressorgenesandde nesadistinctsubgroupofaggressiveERGfusion-positiveprostatecancers.J.Pathol.231,130–141.

Kumar,A.,White,T.A.,MacKenzie,A.P.,Clegg,N.,Lee,C.,Dumpit,R.F.,Co-leman,I.,Ng,S.B.,Salipante,S.J.,Rieder,M.J.,etal.(2011).Exomesequencingidenti esaspectrumofmutationfrequenciesinadvancedandlethalprostatecancers.Proc.Natl.Acad.Sci.USA108,17087–17092.Li,H.,andDurbin,R.(2010).Fastandaccuratelong-readalignmentwithBur-rows-Wheelertransform.Bioinformatics26,589–595.

Liu,W.,Lindberg,J.,Sui,G.,Luo,J.,Egevad,L.,Li,T.,Xie,C.,Wan,M.,Kim,S.T.,Wang,Z.,etal.(2012a).Identi cationofnovelCHD1-associatedcollab-orativealterationsofgenomicstructureandfunctionalassessmentofCHD1inprostatecancer.Oncogene31,3939–3948.

Liu,X.,Ory,V.,Chapman,S.,Yuan,H.,Albanese,C.,Kallakury,B.,Timofeeva,O.A.,Nealon,C.,Dakic,A.,Simic,V.,etal.(2012b).ROCKinhibitorandfeedercellsinducetheconditionalreprogrammingofepithelialcells.Am.J.Pathol.180,599–607.

McKenna,A.,Hanna,M.,Banks,E.,Sivachenko,A.,Cibulskis,K.,Kernytsky,A.,Garimella,K.,Altshuler,D.,Gabriel,S.,Daly,M.,andDePristo,M.A.(2010).TheGenomeAnalysisToolkit:aMapReduceframeworkforanalyzingnext-generationDNAsequencingdata.GenomeRes.20,1297–1303.

Mertz,K.D.,Setlur,S.R.,Dhanasekaran,S.M.,Demichelis,F.,Perner,S.,Tom-lins,S.,Tchinda,J.,Laxman,B.,Vessella,R.L.,Beroukhim,R.,etal.(2007).MolecularcharacterizationofTMPRSS2-ERGgenefusionintheNCI-H660prostatecancercellline:anewperspectiveforanoldmodel.Neoplasia9,200–206.

Navone,N.M.,Olive,M.,Ozen,M.,Davis,R.,Troncoso,P.,Tu,S.M.,Johnston,D.,Pollack,A.,Pathak,S.,vonEschenbach,A.C.,andLogothetis,C.J.(1997).Establishmentoftwohumanprostatecancercelllinesderivedfromasinglebonemetastasis.Clin.CancerRes.3,2493–2500.

Parwani,A.V.,Kronz,J.D.,Genega,E.M.,Gaudin,P.,Chang,S.,andEpstein,J.I.(2004).Prostatecarcinomawithsquamousdifferentiation:ananalysisof33cases.Am.J.Surg.Pathol.28,651–657.

Rathkopf,D.,andScher,H.I.(2013).Androgenreceptorantagonistsincastra-tion-resistantprostatecancer.CancerJ.19,43–49.

Roberts,A.,Trapnell,C.,Donaghey,J.,Rinn,J.L.,andPachter,L.(2011).ImprovingRNA-Seqexpressionestimatesbycorrectingforfragmentbias.GenomeBiol.12,R22.

Ryan,C.J.,Smith,M.R.,DeBono,J.S.,Molina,A.,Logothetis,C.,DeSouza,P.L.,Fizazi,K.,Mainwaring,P.N.,PiulatsRodriguez,J.M.,Ng,S.,etal.(2012).Interimanalysis(IA)resultsofCOU-AA-302,arandomized,phaseIIIstudyofabirateroneacetate(AA)inchemotherapy-naivepatients(pts)withmetastaticcastration-resistantprostatecancer(mCRPC).ASCOMeetingAbstracts30,LBA4518.

Cell159,1–12,September25,2014ª2014ElsevierInc.

Organoid Cultures Derived from Patients with Advanced Prostate Cancer

11

上一页第11页

你可能喜欢

热门文档

相关文档

  • Serum peptidome

    from patients with advanced prostate, bladder, or breast cancer as well as...Regardless of whether the peptidome is derived from the tissue/microenvironment...

  • Cryopreservation of mature monocyte-derived human d...

    [6], advanced melanoma [11], prostate cancer [...from healthy donors and from patients with chronic...In DC cultures of four healthy donors, Freezing ...

站点地图 | 文档上传 | 侵权投诉 | 手机版
本站所有资源均来自互联网,本站只负责收集和整理,均不承担任何法律责任,如有侵权等其它行为请联系我们.
文档下载 Copyright 2013 doc.guandang.net All Rights Reserved.  -  email